EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Comprehensive Evaluation of Quality Indicators: Analyzing the Dutch Breast Cancer Audit

Elfi M. Verheul, Margrietha van der Linde, Hester F. Lingsma, Elvira Vos, Sabine Siesling, Linetta B. Koppert, NBCA Consortium

International Journal of Health Policy and Management · 2025-10-01 · 14 · 8943

DOI: 10.34172/ijhpm.8943 ↗
AbstractBibliografische Angaben

Abstract

Background: Quality indicators (QIs) are widely used to benchmark hospital performance and improve quality of care but are often based on expert opinion rather than data-driven assessment. This study aims to evaluate QIs, using a framework that assesses four criteria: Feasibility, discriminative ability, validity, and reliability. Methods: We used data from the Dutch breast cancer registry (NABON Breast Cancer Audit, NBCA) and included all surgically treated breast cancer patients in the Netherlands between 2021-2023. Eighteen QIs were evaluated. Feasibility was determined by QI numerator completeness, with >90% data availability considered feasible. Discriminative ability was assessed by between-hospital variation in QI scores, where an interquartile range (IQR) >10% indicated good discrimination. Validity was evaluated by the impact of case-mix adjustment and considered low when (pseudo-) R² 75% was considered high. Results: After exclusion of one QI with feasibility

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →